Correction to: A DELPHI consensus statement on antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of mechanical thrombectomy (Neuroradiology, (2021), 63, 4, (627-632), 10.1007/s00234-020-02556-z)

Mayank Goyal, Kirill Orlov, Mary E. Jensen, Allan Taylor, Charles Majoie, Mahesh Jayaraman, Jianmin Liu, Geneviève Milot, Patrick Brouwer, Shinichi Yoshimura, Felipe Albuquerque, Adam Arthur, David Kallmes, Nobuyuki Sakai, Justin F. Fraser, Raul Nogueira, Pengfei Yang, Franziska Dorn, Lucie Thibault, Jens FiehlerRené Chapot, Johanna Maria Ospel

Research output: Contribution to journalComment/debatepeer-review

Abstract

The publisher would like to correct an error in Supplementary table I: Consensus recommendations for the dosage of GPIIb/IIIa receptor inhibitors* Please note the Eptifibatide dosing is incorrect. The correct dose is 2 mcg/kg/min.

Original languageEnglish (US)
Pages (from-to)1391-1392
Number of pages2
JournalNeuroradiology
Volume63
Issue number8
DOIs
StatePublished - Aug 2021

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Correction to: A DELPHI consensus statement on antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of mechanical thrombectomy (Neuroradiology, (2021), 63, 4, (627-632), 10.1007/s00234-020-02556-z)'. Together they form a unique fingerprint.

Cite this